|
New England drug developers made headlines this week with funding news.
—My San Diego colleague Bruce took a look at Applied Proteomics, the five-year-old biotech startup co-founded by MIT-trained computer scientist Danny Hillis. The startup, which raised $22.5 million in funding in... Read more »
The United States is essentially an unpopulated wilderness. If you scattered the citizenry evenly across the country, we’d each have a luxurious eight acres to ourselves. But here’s the weird thing: In a country where the outdoors is so vast, people rarely go... Read more »
Time for an update on Boston’s marketing tech cluster. It’s one of the real strengths of the local entrepreneurial ecosystem. And it looks like it’s getting stronger, with a couple of leaders making news this week. Here is a tale of two companies... Read more »
Last month, Aastrom Biosciences president and CEO Tim Mayleben and his wife, Dawn, announced they are funding a new “venture shaping” program at the University of Michigan.
Venture shaping refers to the process of systematically vetting a nifty idea for a startup, with the idea... Read more »
When Barry Fogel first started developing a new treatment 15 years ago, his main goal was to help his own patients. Fogel, a physician trained in both psychiatry and neurology, saw many patients with a movement disorder called tardive dyskinesia (TD). The condition—which can be... Read more »
Today’s West Coast announcement that Oracle is buying human resources management firm Taleo for $1.9 billion—yes, billion—puts some Boston-area talent and recruiting startups in a new light. Unfortunately, one of them is no longer in Boston…
—Take the Interview, the video-based... Read more »
New England Patriots owner Robert Kraft may still be smarting from his team’s loss to the New York Giants in the Super Bowl, but at least one of Kraft’s other organizations has some good news to cushion the blow: Boston-based Acetylon... Read more »
Senior Vice President of Corporate Development, Avaya
General Partner, Flybridge Capital Partners
Professor, MIT
Visiting Scholar, MIT
Associate Professor of Media Arts and Sciences, MIT
Partner, Latham & Watkins LLP
Distinguished Lecturer, Sloan School of Management at MIT
CEO, Alnylam Pharmaceuticals
CEO, Cambridge Innovation Center
Partner, Advanced Technology Ventures
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
